Literature DB >> 30529082

Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties.

Noemí Encinas1, Mercedes Angulo1, Carlos Astorga1, Montserrat Colilla2, Isabel Izquierdo-Barba3, María Vallet-Regí4.   

Abstract

The design of drug delivery systems needs to consider biocompatibility and host body recognition for an adequate actuation. In this work, mesoporous silica nanoparticles (MSNs) surfaces were successfully modified with two silane molecules to provide mixed-charge brushes (-NH3⊕/-PO3⊝) and well evaluated in terms of surface properties, low-fouling capability and cell uptake in comparison to PEGylated MSNs. The modification process consists in the simultaneous direct-grafting of hydrolysable short chain amino (aminopropyl silanetriol, APST) and phosphonate-based (trihydroxy-silyl-propyl-methyl-phosphonate, THSPMP) silane molecules able to provide a pseudo-zwitterionic nature under physiological pH conditions. Results confirmed that both mixed-charge pseudo-zwitterionic MSNs (ZMSN) and PEG-MSN display a significant reduction of serum protein adhesion and macrophages uptake with respect to pristine MSNs. In the case of ZMSNs, this reduction is up to a 70-90% for protein adsorption and c.a. 60% for cellular uptake. This pseudo-zwitterionic modification has been focused on the aim of local treatment of bacterial infections through the synergistic effect between the inherent antimicrobial effect of mixed-charge system and the levofloxacin antibiotic release profile. These findings open promising future expectations for the effective treatment of bacterial infections through the use of mixed-charge pseudo-zwitterionic MSNs furtive to macrophages and with antimicrobial properties. STATEMENT OF SIGNIFICANCE: Herein a novel antimicrobial mixed-charge pseudo-zwitterionic MSNs based system with low-fouling and reduced cell uptake behavior has been developed. This chemical modification has been performed by the simultaneous grafting of short chain organosilanes, containing amino and phosphonate groups, respectively. This nanocarrier has been tested for local infection treatment through the synergy between the antimicrobial effect of mixed-charge brushes and the levofloxacin antibiotic release profile.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial properties; Levofloxacin release; Low-fouling properties; Macrophage uptake; Mesoporous silica nanoparticles; Mixed-charge brushes; Pseudo-zwitterionic surface

Mesh:

Substances:

Year:  2018        PMID: 30529082      PMCID: PMC6718287          DOI: 10.1016/j.actbio.2018.12.012

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  39 in total

1.  Host tissue as a niche for biomaterial-associated infection.

Authors:  Saj Zaat; Can Broekhuizen; M Riool
Journal:  Future Microbiol       Date:  2010-08       Impact factor: 3.165

Review 2.  Surface modification strategies on mesoporous silica nanoparticles for anti-biofouling zwitterionic film grafting.

Authors:  Yit Lung Khung; Dario Narducci
Journal:  Adv Colloid Interface Sci       Date:  2015-10-31       Impact factor: 12.984

3.  Biocompatibility and levofloxacin delivery of mesoporous materials.

Authors:  Mónica Cicuéndez; Isabel Izquierdo-Barba; María Teresa Portolés; María Vallet-Regí
Journal:  Eur J Pharm Biopharm       Date:  2012-12-27       Impact factor: 5.571

4.  Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.

Authors:  Shu J Lam; Neil M O'Brien-Simpson; Namfon Pantarat; Adrian Sulistio; Edgar H H Wong; Yu-Yen Chen; Jason C Lenzo; James A Holden; Anton Blencowe; Eric C Reynolds; Greg G Qiao
Journal:  Nat Microbiol       Date:  2016-09-12       Impact factor: 17.745

5.  Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications.

Authors:  Shaoyi Jiang; Zhiqiang Cao
Journal:  Adv Mater       Date:  2010-03-05       Impact factor: 30.849

6.  3D scaffold with effective multidrug sequential release against bacteria biofilm.

Authors:  Rafaela García-Alvarez; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Acta Biomater       Date:  2016-11-11       Impact factor: 8.947

7.  Phase behavior of poly(sulfobetaine methacrylate)-grafted silica nanoparticles and their stability in protein solutions.

Authors:  Zhixin Dong; Jun Mao; Muquan Yang; Dapeng Wang; Shuqin Bo; Xiangling Ji
Journal:  Langmuir       Date:  2011-11-29       Impact factor: 3.882

8.  Biocompatible zwitterionic sulfobetaine copolymer-coated mesoporous silica nanoparticles for temperature-responsive drug release.

Authors:  Jiao-Tong Sun; Zhi-Qiang Yu; Chun-Yan Hong; Cai-Yuan Pan
Journal:  Macromol Rapid Commun       Date:  2012-04-05       Impact factor: 5.734

9.  Evaluation of nanoparticles as endocytic tracers in cellular microbiology.

Authors:  Yuying Zhang; Michael Hensel
Journal:  Nanoscale       Date:  2013-08-14       Impact factor: 7.790

10.  Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

Authors:  Marlieke E A de Kraker; Andrew J Stewardson; Stephan Harbarth
Journal:  PLoS Med       Date:  2016-11-29       Impact factor: 11.069

View more
  17 in total

Review 1.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

2.  Impact of the antibiotic-cargo from MSNs on Gram-positive and Gram-negative bacterial biofilms.

Authors:  Anna Aguilar-Colomer; Montserrat Colilla; Isabel Izquierdo-Barba; Carla Jiménez-Jiménez; Ignacio Mahillo; Jaime Esteband; María Vallet-Regí
Journal:  Microporous Mesoporous Mater       Date:  2020-10-07       Impact factor: 5.876

Review 3.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

4.  Zinc oxide nanocrystals as a nanoantibiotic and osteoinductive agent.

Authors:  Nadia Garino; Pasquale Sanvitale; Bianca Dumontel; Marco Laurenti; Montserrat Colilla; Isabel Izquierdo-Barba; Valentina Cauda; Maria Vallet-Regì
Journal:  RSC Adv       Date:  2019-04-11       Impact factor: 4.036

5.  Understanding the interactions of poly(methyl methacrylate) and poly(vinyl chloride) nanoparticles with BHK-21 cell line.

Authors:  Gomathi Mahadevan; Suresh Valiyaveettil
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

6.  Strontium-releasing mesoporous bioactive glasses with anti-adhesive zwitterionic surface as advanced biomaterials for bone tissue regeneration.

Authors:  Carlotta Pontremoli; Isabel Izquierdo-Barba; Giorgia Montalbano; María Vallet-Regí; Chiara Vitale-Brovarone; Sonia Fiorilli
Journal:  J Colloid Interface Sci       Date:  2019-12-14       Impact factor: 8.128

Review 7.  Recent Advances Toward the Use of Mesoporous Silica Nanoparticles for the Treatment of Bacterial Infections.

Authors:  Rafael R Castillo; María Vallet-Regí
Journal:  Int J Nanomedicine       Date:  2021-06-30

Review 8.  Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles.

Authors:  Miguel Gisbert-Garzarán; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2020-05-09       Impact factor: 5.076

Review 9.  Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-01-20       Impact factor: 6.321

Review 10.  Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment.

Authors:  Gabriela Corrêa Carvalho; Rafael Miguel Sábio; Tais de Cássia Ribeiro; Andreia Sofia Monteiro; Daniela Vassalo Pereira; Sidney José Lima Ribeiro; Marlus Chorilli
Journal:  Pharm Res       Date:  2020-09-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.